C

Clinilabs | New Jersey

Research site

(Unclaimed)

Location

4 Industrial Way West 2nd Floor, Eatontown, New Jersey, United States of America

Site insights

Top conditions

Top treatments

PF-06291874

LY03005

BPM31510

DT-216

GV101

INZ-701

Nomlabofusp

MK-6552-003

Dexmedetomidine

MK-6552

Parent organization

This site is a part of Clinilabs

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 21 total trials

A Study to Evaluate the Efficacy and Safety of Subcutaneous Nomlabofusp in Subjects With Friedreich's Ataxia (FORWARD-FA)

To evaluate the efficacy and safety of subcutaneous nomlabofusp in adult and pediatric subjects with Friedreich's ataxia

Enrolling

Friedreich's Ataxia

Friedreich Ataxia

Drug: Placebo

Drug: Nomlabofusp

Status recently updated

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JZP269 in Healthy Male and Female Participants

This study will characterize the safety, tolerability, pharmacokinetics (PK), and pharmacodynamic (PD) of JZP269 in healthy participants.

Not yet enrolling

Enrolling

Healthy Participants

Drug: Placebo

Drug: JZP269

GV101 for Friedreich's Ataxia (FA) Treatment

This is a dose-ranging, randomized, double-blind, placebo-controlled 12-week Phase 2a trial with an up to two week loading dose period. Eligible part...

Not yet enrolling

Friedreich's Ataxia

Drug: GV101

Drug: Placebo

Sublingual Dexmedetomidine for Treating Opioid Withdrawal

A major challenge to seeking treatment for opioid use disorder (OUD) is the withdrawal symptoms associated with cessation of opioid use. The signs an...

Active, not recruiting

Opioid Withdrawal

Opioid Use Disorder

Other: Placebo

Drug: BXCL501 (240 micrograms)